Regular review: medical management of osteoarthritis.
作者信息
Walker-Bone K, Javaid K, Arden N, Cooper C
机构信息
MRC Environmental Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton SO16 6YD.
出版信息
BMJ. 2000 Oct 14;321(7266):936-40. doi: 10.1136/bmj.321.7266.936.
Abstract
摘要
相似文献
1
Regular review: medical management of osteoarthritis.定期回顾：骨关节炎的医学管理
BMJ. 2000 Oct 14;321(7266):936-40. doi: 10.1136/bmj.321.7266.936.
2
Non-surgical treatment of osteoarthritis: a half century of "advances".骨关节炎的非手术治疗：半个世纪的“进展”。
Ann Rheum Dis. 2004 Feb;63(2):117-22. doi: 10.1136/ard.2002.004606.
3
Arthritis. Timely treatments for an ageless disease.关节炎。针对一种无年龄界限疾病的及时治疗。
FDA Consum. 2000 May-Jun;34(3):27-9, 31-3.
4
Treatment options for osteoarthritis: considerations for older adults.骨关节炎的治疗选择：老年人的考量因素
Hosp Pract (1995). 2011 Feb;39(1):62-73. doi: 10.3810/hp.2011.02.375.
5
Treatment options for osteoarthritis.骨关节炎的治疗选择。
Orthopedics. 2005 Feb;28(2 Suppl):s215-20. doi: 10.3928/0147-7447-20050202-06.
6
Updated guidelines include new drugs and therapies for the treatment of osteoarthritis.
Rep Med Guidel Outcomes Res. 2000 Oct 26;11(21):1-2, 5.
7
Tackling osteoarthritis during COVID-19 pandemic.应对 COVID-19 大流行中的骨关节炎。
Ann Rheum Dis. 2021 Feb;80(2):151-153. doi: 10.1136/annrheumdis-2020-218372. Epub 2020 Sep 28.
8
Osteoarthritis: current concepts in diagnosis and management.骨关节炎：诊断与管理的当前概念
Am Fam Physician. 2000 Mar 15;61(6):1795-804.
9
An action plan for relieving joint pain.缓解关节疼痛的行动计划。
Johns Hopkins Med Lett Health After 50. 2001 Mar;13(1):6-7.
10
Medical management of osteoarthritis.骨关节炎的医学管理
Mayo Clin Proc. 2001 May;76(5):533-9. doi: 10.4065/76.5.533.
引用本文的文献
1
Mental health and health-related quality of life among adults with osteoarthritis: A national population-based study.骨关节炎成年患者的心理健康及与健康相关的生活质量：一项基于全国人口的研究。
PLoS One. 2025 Jun 18;20(6):e0325780. doi: 10.1371/journal.pone.0325780. eCollection 2025.
2
A Clinical Prediction Rule for Predicting the Health-related Quality of Life after 5 Months in Patients with Knee Osteoarthritis Undergoing Conservative Treatment.预测接受保守治疗的膝关节骨关节炎患者5个月后健康相关生活质量的临床预测规则。
Phys Ther Res. 2024;27(3):158-165. doi: 10.1298/ptr.E10296. Epub 2024 Nov 28.
3
Chondroprotective effects of larvae as an edible insect on osteoarthritis in mice.幼虫作为一种可食用昆虫对小鼠骨关节炎的软骨保护作用。
Food Sci Nutr. 2023 Oct 6;11(12):7887-7899. doi: 10.1002/fsn3.3706. eCollection 2023 Dec.
4
The Efficacy and Safety of Intra-articular Low Molecular Weight Fraction of Human Serum Albumin for the Management of Moderate to Moderately Severe Knee Osteoarthritis: A Systematic Review and Meta-Analysis.关节腔内注射人血清白蛋白低分子量组分治疗中度至中度重度膝骨关节炎的疗效与安全性：一项系统评价和荟萃分析
Cureus. 2023 Jun 30;15(6):e41240. doi: 10.7759/cureus.41240. eCollection 2023 Jun.
5
Adaptation and Implementation of a Shared Decision-Making Tool From One Health Context to Another: Partnership Approach Using Mixed Methods.从一个健康背景到另一个健康背景的共享决策工具的调整和实施：使用混合方法的伙伴关系方法。
J Med Internet Res. 2023 Jul 5;25:e42551. doi: 10.2196/42551.
6
Osteochondral regenerative engineering: challenges, state-of-the-art and translational perspectives.骨软骨再生工程：挑战、现状与转化前景
Regen Biomater. 2022 Dec 26;10:rbac109. doi: 10.1093/rb/rbac109. eCollection 2023.
7
Osteoarthritis: Can We Do Better?骨关节炎：我们能做得更好吗？
Cureus. 2022 Nov 14;14(11):e31505. doi: 10.7759/cureus.31505. eCollection 2022 Nov.
8
Computational investigation of interface printing patterns within 3D printed multilayered scaffolds for osteochondral tissue engineering.计算研究用于骨软骨组织工程的 3D 打印多层支架内界面打印模式。
Biofabrication. 2022 Feb 23;14(2). doi: 10.1088/1758-5090/ac5220.
9
Biomechanical Aspects of Osteochondral Regeneration: Implications and Strategies for Three-Dimensional Bioprinting.骨软骨再生的生物力学方面：三维生物打印的意义和策略。
Tissue Eng Part B Rev. 2022 Aug;28(4):766-788. doi: 10.1089/ten.TEB.2021.0101. Epub 2021 Nov 2.
10
Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-analysis.乳香及其提取物治疗骨关节炎患者的有效性：系统评价和荟萃分析。
BMC Complement Med Ther. 2020 Jul 17;20(1):225. doi: 10.1186/s12906-020-02985-6.
本文引用的文献
1
EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT).欧洲抗风湿病联盟（EULAR）膝关节骨关节炎管理推荐：国际临床研究包括治疗试验常务委员会（ESCISIT）特别工作组报告
Ann Rheum Dis. 2000 Dec;59(12):936-44. doi: 10.1136/ard.59.12.936.
2
Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis.氨基葡萄糖和软骨素治疗骨关节炎：系统质量评估与荟萃分析。
JAMA. 2000 Mar 15;283(11):1469-75. doi: 10.1001/jama.283.11.1469.
3
Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs.与非甾体抗炎药相比，罗非昔布对上消化道的不良影响。
JAMA. 1999 Nov 24;282(20):1929-33. doi: 10.1001/jama.282.20.1929.
4
Hyaluronic acid in the treatment of osteoarthritis of the knee.透明质酸治疗膝骨关节炎
Rheumatology (Oxford). 1999 Jul;38(7):602-7. doi: 10.1093/rheumatology/38.7.602.
5
Effectiveness of home exercise on pain and disability from osteoarthritis of the knee: a randomised controlled trial.家庭锻炼对膝关节骨关节炎疼痛和功能障碍的有效性：一项随机对照试验。
Ann Rheum Dis. 1999 Jan;58(1):15-9. doi: 10.1136/ard.58.1.15.
6
COX-2 inhibitors.环氧化酶-2抑制剂
Lancet. 1999 Jan 23;353(9149):307-14. doi: 10.1016/s0140-6736(98)12154-2.
7
8
North of England evidence based guideline development project: summary guideline for non-steroidal anti-inflammatory drugs versus basic analgesia in treating the pain of degenerative arthritis. The North of England Non-Steroidal Anti-Inflammatory Drug Guideline Development Group.英格兰北部循证指南制定项目：非甾体抗炎药与基础镇痛药治疗退行性关节炎疼痛的简要指南。英格兰北部非甾体抗炎药指南制定小组。
BMJ. 1998 Aug 22;317(7157):526-30. doi: 10.1136/bmj.317.7157.526.
9
Viscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee.透明质酸钠凝胶（hylan G-F 20）关节腔注射治疗膝骨关节炎的26周疗效与安全性对照试验
Clin Ther. 1998 May-Jun;20(3):410-23. doi: 10.1016/s0149-2918(98)80052-0.
10
Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs.局部应用非甾体抗炎药的定量系统评价
BMJ. 1998 Jan 31;316(7128):333-8. doi: 10.1136/bmj.316.7128.333.
Zotero 插件